Free Trial
→ The one number Musk can't hide in the S-1 (From Behind the Markets) (Ad)tc pixel Free SOLV Stock Alerts

Solventum (SOLV) Financials

Solventum logo
$74.43 -0.67 (-0.89%)
Closing price 05/13/2026 03:59 PM Eastern
Extended Trading
$74.43 +0.00 (+0.00%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Solventum

Annual Income Statements for Solventum

This table shows Solventum's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 1,343 1,346 479 1,556
Consolidated Net Income / (Loss)		 1,343 1,346 479 1,556
Net Income / (Loss) Continuing Operations		 1,343 1,346 478 1,556
Total Pre-Tax Income 		1,692 1,667 605 1,713
Total Operating Income		 1,693 1,692 1,036 2,181
Total Gross Profit		 4,695 4,693 4,593 4,451
Total Revenue		 8,130 8,197 8,254 8,325
Operating Revenue		 8,130 8,197 8,254 8,325
Total Cost of Revenue		 3,435 3,504 3,661 3,874
Operating Cost of Revenue		 3,435 3,504 3,661 3,874
Total Operating Expenses		 3,002 3,001 3,557 2,270
Selling, General & Admin Expense		 2,235 2,299 2,782 3,080
Research & Development Expense		 767 758 775 739
Restructuring Charge		 - -56 0.00 -1,549
Total Other Income / (Expense), net		 -1.00 -25 -431 -468
Interest Expense		 - 0.00 0.00 82
Interest & Investment Income		 0.00 0.00 -367 -347
Other Income / (Expense), net		 -1.00 -25 -64 -39
Income Tax Expense		 349 321 127 157
Basic Earnings per Share		 $7.78 $7.79 $2.77 $8.94
Weighted Average Basic Shares Outstanding		 172.70M 172.70M 173.20M 174.10M
Diluted Earnings per Share		 $7.78 $7.79 $2.76 $8.88
Weighted Average Diluted Shares Outstanding		 172.70M 172.70M 173.70M 175.30M
Weighted Average Basic & Diluted Shares Outstanding		 - - 172.99M 173.49M

Quarterly Income Statements for Solventum

This table shows Solventum's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 460 272 237 89 122 31 137 90 1,266 63 12
Consolidated Net Income / (Loss)		 460 272 237 89 122 31 137 90 1,266 63 13
Net Income / (Loss) Continuing Operations		 460 272 237 89 122 30 136 90 1,266 64 12
Total Pre-Tax Income 		500 391 329 96 167 13 38 103 1,514 58 16
Total Operating Income		 504 406 381 244 275 136 152 214 1,690 125 81
Total Gross Profit		 1,209 1,158 1,172 1,137 1,165 1,119 1,114 1,175 1,135 1,027 1,097
Total Revenue		 2,074 2,036 2,016 2,081 2,082 2,075 2,070 2,161 2,096 1,998 2,007
Operating Revenue		 2,074 2,036 2,016 2,081 2,082 2,075 2,070 2,161 2,096 1,998 2,007
Total Cost of Revenue		 865 878 844 944 917 956 956 986 961 971 911
Operating Cost of Revenue		 865 878 844 944 917 956 956 986 961 971 911
Total Operating Expenses		 705 752 791 893 890 983 962 961 -555 902 1,016
Selling, General & Admin Expense		 525 562 596 701 701 784 769 772 780 759 827
Research & Development Expense		 180 190 195 192 189 199 193 189 183 174 189
Total Other Income / (Expense), net		 -4.00 -15 -52 -148 -108 -123 -115 -111 -176 -66 -66
Interest & Investment Income		 0.00 - -39 -114 -107 -107 -104 -103 -89 -51 -62
Other Income / (Expense), net		 -4.00 -15 -13 -34 -1.00 -16 -11 -8.00 -5.00 -15 -4.00
Income Tax Expense		 40 119 92 7.00 45 -17 -99 13 248 -5.00 3.00
Basic Earnings per Share		 $2.66 $1.57 $1.37 $0.51 $0.70 $0.19 $0.79 $0.52 $7.26 $0.37 $0.07
Weighted Average Basic Shares Outstanding		 172.70M 172.70M 172.70M 173.20M 173.40M 173.20M 173.70M 174.10M 174.30M 174.10M 174.20M
Diluted Earnings per Share		 $2.66 $1.57 $1.37 $0.51 $0.70 $0.18 $0.78 $0.51 $7.22 $0.37 $0.07
Weighted Average Diluted Shares Outstanding		 172.70M 172.70M 172.70M 173.50M 173.90M 173.70M 174.80M 175.20M 175.40M 175.30M 175.50M
Weighted Average Basic & Diluted Shares Outstanding		 - 0.00 172.71M 172.71M 172.75M 172.99M 173.01M 173.39M 173.45M 173.49M 173.17M

Annual Cash Flow Statements for Solventum

This table details how cash moves in and out of Solventum's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -30 133 568 116
Net Cash From Operating Activities		 1,679 1,915 1,185 369
Net Cash From Continuing Operating Activities		 1,679 1,915 1,185 369
Net Income / (Loss) Continuing Operations		 1,343 1,346 479 1,556
Consolidated Net Income / (Loss)		 1,343 1,346 479 1,556
Depreciation Expense		 578 561 555 489
Non-Cash Adjustments To Reconcile Net Income		 101 24 -249 -1,448
Changes in Operating Assets and Liabilities, net		 -343 -16 400 -228
Net Cash From Investing Activities		 -253 -230 -380 2,797
Net Cash From Continuing Investing Activities		 -253 -230 -380 2,797
Purchase of Property, Plant & Equipment		 -251 -290 -380 -379
Acquisitions		 - 0.00 0.00 -696
Divestitures		 0.00 60 0.00 3,890
Other Investing Activities, net		 -2.00 0.00 0.00 -18
Net Cash From Financing Activities		 -1,460 -1,552 -240 -3,057
Net Cash From Continuing Financing Activities		 -1,460 -1,552 -240 -3,057
Repayment of Debt		 -4.00 1.00 -292 -3,024
Issuance of Debt		 0.00 0.00 8,303 0.00
Other Financing Activities, net		 -1,456 -1,553 -8,251 -33
Effect of Exchange Rate Changes		 4.00 0.00 3.00 7.00
Cash Interest Paid		 0.00 0.00 287 442
Cash Income Taxes Paid		 0.00 0.00 244 181

Quarterly Cash Flow Statements for Solventum

This table details how cash moves in and out of Solventum's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 3.00 152 802 -99 -125 -10 -223 -45 1,148 -764 -318
Net Cash From Operating Activities		 493 547 442 355 169 219 29 169 76 95 -189
Net Cash From Continuing Operating Activities		 493 547 442 355 169 219 29 169 76 95 -188
Net Income / (Loss) Continuing Operations		 460 272 237 89 122 31 137 90 1,266 63 13
Consolidated Net Income / (Loss)		 460 272 237 89 122 31 137 90 1,266 63 13
Depreciation Expense		 144 139 139 133 133 150 129 122 121 117 135
Non-Cash Adjustments To Reconcile Net Income		 -40 17 13 -163 -126 -143 58 51 -1,522 -35 -35
Changes in Operating Assets and Liabilities, net		 -71 119 53 296 40 181 -295 -94 211 -50 -301
Net Cash From Investing Activities		 -6.00 -88 -102 -58 -93 -127 -114 -110 3,766 -745 -77
Net Cash From Continuing Investing Activities		 -6.00 -88 -102 -58 -93 -127 -114 -110 3,766 -745 -77
Purchase of Property, Plant & Equipment		 -66 -88 -102 -58 -93 -127 -109 -110 -97 -63 -84
Other Investing Activities, net		 - - 0.00 - - - -5.00 - -7.00 -6.00 7.00
Net Cash From Financing Activities		 -485 -306 462 -396 -202 -104 -139 -110 -2,693 -115 -50
Net Cash From Continuing Financing Activities		 -485 -306 462 -396 -202 -104 -139 -110 -2,693 -115 -50
Repayment of Debt		 2.00 -1.00 10 - -202 -100 -108 -111 -2,702 -103 -31
Repurchase of Common Equity		 - - - - - - 0.00 - - - -67
Issuance of Debt		 - - 8,303 - - - 0.00 - - - 46
Other Financing Activities, net		 -487 -305 -7,851 -396 - -4.00 -31 1.00 9.00 -12 2.00
Effect of Exchange Rate Changes		 1.00 -1.00 0.00 - 1.00 2.00 1.00 6.00 -1.00 1.00 -2.00
Other Net Changes in Cash		 - - 0.00 - - - 0.00 - - - 0.00

Annual Balance Sheets for Solventum

This table presents Solventum's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets		 13,943 14,457 14,294
Total Current Assets		 2,519 3,249 3,859
Cash & Equivalents		 194 762 878
Accounts Receivable		 1,313 1,229 1,184
Inventories, net		 857 965 1,066
Other Current Assets		 155 293 731
Plant, Property, & Equipment, net		 1,457 1,622 1,326
Total Noncurrent Assets		 9,967 9,586 9,110
Goodwill		 6,535 6,377 5,704
Intangible Assets		 2,902 2,544 2,592
Other Noncurrent Operating Assets		 530 665 814
Total Liabilities & Shareholders' Equity		 13,943 14,457 14,294
Total Liabilities		 2,277 11,498 9,245
Total Current Liabilities		 1,728 2,703 3,136
Short-Term Debt		 0.00 200 0.00
Accounts Payable		 477 618 687
Accrued Expenses		 0.00 272 435
Current Deferred Revenue		 574 572 621
Other Current Liabilities		 677 1,041 1,393
Total Noncurrent Liabilities		 549 8,795 6,109
Long-Term Debt		 0.00 7,810 5,035
Noncurrent Deferred & Payable Income Tax Liabilities		 231 225 164
Noncurrent Employee Benefit Liabilities		 166 350 363
Other Noncurrent Operating Liabilities		 152 410 547
Commitments & Contingencies		 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 11,666 2,959 5,049
Total Preferred & Common Equity		 11,666 2,959 5,049
Total Common Equity		 11,666 2,959 5,050
Common Stock		 0.00 3,773 3,878
Retained Earnings		 0.00 242 1,797
Treasury Stock		 - - 0.00
Accumulated Other Comprehensive Income / (Loss)		 -337 -1,056 -625

Quarterly Balance Sheets for Solventum

This table presents Solventum's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 13,943 14,711 14,578 14,745 14,457 14,527 15,074 13,973 14,097
Total Current Assets		 2,519 3,359 3,363 3,354 3,249 3,053 3,208 4,407 3,583
Cash & Equivalents		 194 996 897 772 762 534 492 1,642 561
Accounts Receivable		 1,313 1,220 1,317 1,327 1,229 1,111 1,255 1,176 1,180
Inventories, net		 857 901 899 953 965 866 962 1,049 1,089
Other Current Assets		 155 242 250 302 293 249 331 540 754
Plant, Property, & Equipment, net		 1,457 1,491 1,537 1,599 1,622 1,198 1,313 1,336 1,543
Total Noncurrent Assets		 9,967 9,861 9,678 9,792 9,586 10,276 10,553 8,230 8,971
Goodwill		 6,535 6,468 6,447 6,592 6,377 4,991 5,274 5,260 5,626
Intangible Assets		 2,902 2,810 2,724 2,651 2,544 2,365 2,302 2,223 2,497
Other Noncurrent Operating Assets		 530 583 507 549 665 814 917 747 848
Total Liabilities & Shareholders' Equity		 13,943 14,711 14,578 14,745 14,457 14,527 15,074 13,973 14,097
Total Liabilities		 2,277 10,860 11,711 11,553 11,498 11,265 11,429 8,987 9,128
Total Current Liabilities		 1,728 1,854 2,571 2,904 2,703 2,566 2,620 2,938 3,346
Short-Term Debt		 0.00 - - 300 200 100 0.00 0.00 505
Accounts Payable		 477 587 495 560 618 604 643 669 699
Accrued Expenses		 0.00 - 611 450 272 356 355 464 337
Current Deferred Revenue		 574 566 505 563 572 558 557 576 613
Other Current Liabilities		 677 701 960 1,031 1,041 891 1,011 1,229 1,192
Total Noncurrent Liabilities		 549 9,006 9,140 8,649 8,795 8,699 8,809 6,049 5,781
Long-Term Debt		 0.00 8,303 8,306 7,809 7,810 7,813 7,815 5,137 4,575
Noncurrent Deferred & Payable Income Tax Liabilities		 231 211 214 214 225 226 231 169 161
Noncurrent Employee Benefit Liabilities		 166 321 315 321 350 334 354 306 360
Other Noncurrent Operating Liabilities		 152 171 305 305 410 279 371 437 685
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 11,666 3,851 2,867 3,192 2,959 3,262 3,645 4,986 4,969
Total Preferred & Common Equity		 11,666 3,851 2,867 3,192 2,959 3,262 3,645 4,986 4,969
Total Common Equity		 11,666 3,851 2,867 3,192 2,959 3,262 3,645 4,986 4,970
Common Stock		 0.00 - 3,721 3,746 3,773 3,783 3,808 3,856 3,897
Retained Earnings		 0.00 - 89 211 242 378 468 1,734 1,810
Treasury Stock		 - - - - - - - - -67
Accumulated Other Comprehensive Income / (Loss)		 -337 -958 -943 -765 -1,056 -899 -631 -604 -670

Annual Metrics And Ratios for Solventum

This table displays calculated financial ratios and metrics derived from Solventum's official financial filings.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - -
Revenue Growth		 0.00% 0.82% 0.70% 0.86%
EBITDA Growth		 0.00% -1.85% -31.46% 72.30%
EBIT Growth		 0.00% -1.48% -41.69% 120.37%
NOPAT Growth		 0.00% 1.67% -40.09% 142.03%
Net Income Growth		 0.00% 0.22% -64.41% 224.84%
EPS Growth		 0.00% 0.13% -64.57% 221.74%
Operating Cash Flow Growth		 0.00% 14.06% -38.12% -68.86%
Free Cash Flow Firm Growth		 0.00% 0.00% 120.62% 43.08%
Invested Capital Growth		 0.00% 0.00% -11.03% -9.80%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% -0.92%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% -1.61%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% -0.46%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% -1.02%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 2.10%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 2.19%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% -25.15%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% -26.38%
Invested Capital Q/Q Growth		 0.00% 0.00% -3.06% 8.56%
Profitability Metrics		 - - - -
Gross Margin		 57.75% 57.25% 55.65% 53.47%
EBITDA Margin		 27.92% 27.18% 18.50% 31.60%
Operating Margin		 20.82% 20.64% 12.55% 26.20%
EBIT Margin		 20.81% 20.34% 11.78% 25.73%
Profit (Net Income) Margin		 16.52% 16.42% 5.80% 18.69%
Tax Burden Percent		 79.37% 80.74% 79.17% 90.83%
Interest Burden Percent		 100.00% 100.00% 62.24% 79.97%
Effective Tax Rate		 20.63% 19.26% 20.99% 9.17%
Return on Invested Capital (ROIC)		 0.00% 23.82% 7.55% 20.41%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 44.63% -2.08% 12.96%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -0.74% -1.00% 18.45%
Return on Equity (ROE)		 0.00% 23.08% 6.55% 38.86%
Cash Return on Invested Capital (CROIC)		 0.00% -176.18% 19.22% 30.71%
Operating Return on Assets (OROA)		 0.00% 11.96% 6.85% 14.90%
Return on Assets (ROA)		 0.00% 9.65% 3.37% 10.82%
Return on Common Equity (ROCE)		 0.00% 23.08% 6.55% 38.87%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 11.54% 16.19% 0.00%
Net Operating Profit after Tax (NOPAT)		 1,344 1,366 819 1,981
NOPAT Margin		 16.53% 16.67% 9.92% 23.80%
Net Nonoperating Expense Percent (NNEP)		 0.00% -20.81% 9.63% 7.45%
Return On Investment Capital (ROIC_SIMPLE)		 - 11.71% 7.46% 19.65%
Cost of Revenue to Revenue		 42.25% 42.75% 44.35% 46.53%
SG&A Expenses to Revenue		 27.49% 27.36% 33.70% 37.00%
R&D to Revenue		 9.43% 9.25% 9.39% 8.88%
Operating Expenses to Revenue		 36.93% 36.61% 43.09% 27.27%
Earnings before Interest and Taxes (EBIT)		 1,692 1,667 972 2,142
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2,270 2,228 1,527 2,631
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 0.00 0.00 3.86 2.72
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 1.38 1.65
Price to Earnings (P/E)		 0.00 0.00 23.82 8.83
Dividend Yield		 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 4.20% 11.32%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 1.83 1.94
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 2.26 2.15
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 12.22 6.80
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 19.20 8.36
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 22.80 9.04
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 15.75 48.51
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 8.96 6.00
Leverage & Solvency		 - - - -
Debt to Equity		 0.00 0.00 2.71 1.00
Long-Term Debt to Equity		 0.00 0.00 2.64 1.00
Financial Leverage		 0.00 -0.02 0.48 1.42
Leverage Ratio		 0.00 1.20 1.94 3.59
Compound Leverage Factor		 0.00 1.20 1.21 2.87
Debt to Total Capital		 0.00% 0.00% 73.02% 49.93%
Short-Term Debt to Total Capital		 0.00% 0.00% 1.82% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 71.20% 49.93%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 100.00% 26.98% 50.08%
Debt to EBITDA		 0.00 0.00 5.25 1.91
Net Debt to EBITDA		 0.00 0.00 4.75 1.58
Long-Term Debt to EBITDA		 0.00 0.00 5.11 1.91
Debt to NOPAT		 0.00 0.00 9.79 2.54
Net Debt to NOPAT		 0.00 0.00 8.85 2.10
Long-Term Debt to NOPAT		 0.00 0.00 9.54 2.54
Altman Z-Score		 0.00 0.00 1.46 2.21
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% -0.01%
Liquidity Ratios		 - - - -
Current Ratio		 0.00 1.46 1.20 1.23
Quick Ratio		 0.00 0.87 0.74 0.66
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -10,106 2,084 2,981
Operating Cash Flow to CapEx		 668.92% 660.34% 311.84% 97.36%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 36.36
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 4.50
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 -0.12
Efficiency Ratios		 - - - -
Asset Turnover		 0.00 0.59 0.58 0.58
Accounts Receivable Turnover		 0.00 6.24 6.49 6.90
Inventory Turnover		 0.00 4.09 4.02 3.81
Fixed Asset Turnover		 0.00 5.63 5.36 5.65
Accounts Payable Turnover		 0.00 7.35 6.69 5.94
Days Sales Outstanding (DSO)		 0.00 58.47 56.20 52.90
Days Inventory Outstanding (DIO)		 0.00 89.27 90.83 95.68
Days Payable Outstanding (DPO)		 0.00 49.69 54.59 61.48
Cash Conversion Cycle (CCC)		 0.00 98.05 92.45 87.10
Capital & Investment Metrics		 - - - -
Invested Capital		 0.00 11,472 10,207 9,207
Invested Capital Turnover		 0.00 1.43 0.76 0.86
Increase / (Decrease) in Invested Capital		 0.00 11,472 -1,265 -1,000
Enterprise Value (EV)		 0.00 0.00 18,660 17,901
Market Capitalization		 0.00 0.00 11,412 13,744
Book Value per Share		 $0.00 $67.55 $17.13 $29.12
Tangible Book Value per Share		 $0.00 $12.91 ($34.51) ($18.71)
Total Capital		 0.00 11,666 10,969 10,084
Total Debt		 0.00 0.00 8,010 5,035
Total Long-Term Debt		 0.00 0.00 7,810 5,035
Net Debt		 0.00 -194 7,248 4,157
Capital Expenditures (CapEx)		 251 290 380 379
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 597 -16 -155
Debt-free Net Working Capital (DFNWC)		 0.00 791 746 723
Net Working Capital (NWC)		 0.00 791 546 723
Net Nonoperating Expense (NNE)		 0.79 20 340 425
Net Nonoperating Obligations (NNO)		 0.00 -194 7,248 4,158
Total Depreciation and Amortization (D&A)		 578 561 555 489
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 7.28% -0.19% -1.86%
Debt-free Net Working Capital to Revenue		 0.00% 9.65% 9.04% 8.68%
Net Working Capital to Revenue		 0.00% 9.65% 6.62% 8.68%
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $2.77 $8.94
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 173.20M 174.10M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $2.76 $8.88
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 173.70M 175.30M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 172.99M 173.49M
Normalized Net Operating Profit after Tax (NOPAT)		 1,344 1,366 819 574
Normalized NOPAT Margin		 16.53% 16.67% 9.92% 6.90%
Pre Tax Income Margin		 20.81% 20.34% 7.33% 20.58%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 26.12
NOPAT to Interest Expense		 0.00 0.00 0.00 24.16
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 21.50
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 19.54
Payout Ratios		 - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Solventum

This table displays calculated financial ratios and metrics derived from Solventum's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 173,493,005.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 173,493,005.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 0.07
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.25% 0.24% 0.39% 1.92% 2.68% 3.84% 0.67% -3.71% -3.04%
EBITDA Growth		 0.00% 0.00% -0.20% -37.18% -36.80% -49.06% -46.75% -4.37% 343.73% -15.93% -21.48%
EBIT Growth		 0.00% 0.00% 1.38% -49.15% -45.20% -69.31% -61.68% -1.90% 514.96% -8.33% -45.39%
NOPAT Growth		 0.00% 0.00% -6.84% -30.21% -56.67% 11.12% 99.67% -17.34% 603.43% -56.74% -87.99%
Net Income Growth		 0.00% 0.00% -19.11% -72.27% -73.48% -88.60% -42.19% 1.12% 937.70% 103.23% -90.51%
EPS Growth		 0.00% 0.00% -19.41% -72.58% -73.68% -88.54% -43.07% 0.00% 931.43% 105.56% -91.03%
Operating Cash Flow Growth		 0.00% 0.00% -13.16% -3.01% -65.72% -59.96% -93.44% -52.39% -55.03% -56.62% -751.72%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 130.87% 116.23% 133.51% -28.06% -132.09%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% -11.03% -25.20% -14.05% -19.45% -9.80% 13.71%
Revenue Q/Q Growth		 -0.10% -1.83% 0.00% 3.22% 0.05% -0.34% -0.24% 4.40% -3.01% -4.68% 0.45%
EBITDA Q/Q Growth		 17.95% -17.70% 0.00% -32.35% 18.66% -33.66% 0.00% 21.48% 450.61% -87.43% -6.61%
EBIT Q/Q Growth		 21.07% -21.80% 0.00% -42.93% 30.48% -56.20% 17.50% 46.10% 717.96% -93.47% -30.00%
NOPAT Q/Q Growth		 43.06% -39.09% 0.00% -17.58% -11.19% 56.22% 74.61% -65.88% 655.75% -90.39% -51.53%
Net Income Q/Q Growth		 43.30% -40.87% 0.00% -62.45% 37.08% -74.59% 341.94% -34.31% 1,306.67% -95.02% -79.37%
EPS Q/Q Growth		 43.01% -40.98% 0.00% -62.77% 37.25% -74.29% 333.33% -34.62% 1,315.69% -94.88% -81.08%
Operating Cash Flow Q/Q Growth		 34.70% 10.95% 0.00% -19.68% -52.39% 29.59% -86.76% 482.76% -55.03% 25.00% -298.95%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 7.66% -2.77% 115.29% 112.81% -51.46% 112.21% -67.19% -194.93%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% -7.90% 2.46% -3.06% -18.23% 5.82% -3.97% 8.56% 3.07%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 58.29% 56.88% 58.13% 54.64% 55.96% 53.93% 53.82% 54.37% 54.15% 51.40% 54.66%
EBITDA Margin		 31.05% 26.03% 25.15% 16.48% 19.55% 13.01% 13.04% 15.18% 86.16% 11.36% 10.56%
Operating Margin		 24.30% 19.94% 18.90% 11.73% 13.21% 6.55% 7.34% 9.90% 80.63% 6.26% 4.04%
EBIT Margin		 24.11% 19.20% 18.25% 10.09% 13.16% 5.78% 6.81% 9.53% 80.39% 5.51% 3.84%
Profit (Net Income) Margin		 22.18% 13.36% 11.76% 4.28% 5.86% 1.49% 6.62% 4.16% 60.40% 3.15% 0.65%
Tax Burden Percent		 92.00% 69.57% 72.04% 92.71% 73.05% 238.46% 360.53% 87.38% 83.62% 108.62% 81.25%
Interest Burden Percent		 100.00% 100.00% 89.40% 45.71% 60.95% 10.83% 26.95% 50.00% 89.85% 52.73% 20.78%
Effective Tax Rate		 8.00% 30.43% 27.96% 7.29% 26.95% -130.77% -260.53% 12.62% 16.38% -8.62% 18.75%
Return on Invested Capital (ROIC)		 0.00% 9.91% 0.00% 0.00% 0.00% 11.52% 22.55% 7.60% 59.60% 5.83% 3.04%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 15.29% 0.00% 0.00% 0.00% 3.50% 15.92% 6.06% 56.88% 4.55% 1.94%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -0.25% 0.00% 0.00% 0.00% 1.69% 27.73% 11.72% 75.34% 6.48% 2.26%
Return on Equity (ROE)		 0.00% 9.66% 0.00% 0.00% 0.00% 13.20% 50.29% 19.31% 134.94% 12.31% 5.30%
Cash Return on Invested Capital (CROIC)		 0.00% -88.09% 0.00% 0.00% 0.00% 19.22% 38.80% 24.72% 42.60% 30.71% 7.21%
Operating Return on Assets (OROA)		 0.00% 11.29% 0.00% 0.00% 0.00% 3.36% 3.87% 5.39% 47.04% 3.19% 2.21%
Return on Assets (ROA)		 0.00% 7.85% 0.00% 0.00% 0.00% 0.87% 3.76% 2.36% 35.34% 1.83% 0.37%
Return on Common Equity (ROCE)		 0.00% 9.66% 0.00% 0.00% 0.00% 13.20% 50.29% 19.31% 134.94% 12.31% 5.30%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 11.62% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 464 282 274 226 201 314 548 187 1,413 136 66
NOPAT Margin		 22.36% 13.87% 13.61% 10.87% 9.65% 15.13% 26.47% 8.65% 67.42% 6.80% 3.28%
Net Nonoperating Expense Percent (NNEP)		 0.00% -5.38% 1.03% 3.70% 2.15% 8.02% 6.63% 1.54% 2.72% 1.28% 1.10%
Return On Investment Capital (ROIC_SIMPLE)		 - 2.42% - - - 2.86% 4.90% 1.63% 13.96% 1.35% 0.65%
Cost of Revenue to Revenue		 41.71% 43.12% 41.87% 45.36% 44.04% 46.07% 46.18% 45.63% 45.85% 48.60% 45.39%
SG&A Expenses to Revenue		 25.31% 27.60% 29.56% 33.69% 33.67% 37.78% 37.15% 35.72% 37.21% 37.99% 41.21%
R&D to Revenue		 8.68% 9.33% 9.67% 9.23% 9.08% 9.59% 9.32% 8.75% 8.73% 8.71% 9.42%
Operating Expenses to Revenue		 33.99% 36.94% 39.24% 42.91% 42.75% 47.37% 46.47% 44.47% -26.48% 45.15% 50.62%
Earnings before Interest and Taxes (EBIT)		 500 391 368 210 274 120 141 206 1,685 110 77
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 644 530 507 343 407 270 270 328 1,806 227 212
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 3.19 3.77 3.86 4.03 3.60 2.54 2.72 2.28
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 1.38 1.58 1.56 1.51 1.65 1.37
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 23.82 34.71 34.53 8.31 8.83 7.92
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 4.20% 2.88% 2.90% 12.04% 11.32% 12.63%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 1.61 1.84 1.83 2.46 2.31 1.90 1.94 1.67
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 2.26 2.47 2.44 1.92 2.15 1.92
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 12.22 15.92 16.03 6.04 6.80 6.16
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 19.20 27.56 27.59 7.51 8.36 7.63
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 22.80 21.14 22.29 8.07 9.04 8.87
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 15.75 26.60 34.89 32.76 48.51 104.95
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 8.96 5.43 8.66 3.99 6.00 24.65
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 2.16 2.90 2.54 2.71 2.43 2.14 1.03 1.00 1.02
Long-Term Debt to Equity		 0.00 0.00 2.16 2.90 2.45 2.64 2.40 2.14 1.03 1.00 0.92
Financial Leverage		 0.00 -0.02 1.90 2.58 2.30 0.48 1.74 1.93 1.32 1.42 1.17
Leverage Ratio		 0.00 1.20 3.82 5.08 4.62 1.94 4.11 4.55 3.51 3.59 3.48
Compound Leverage Factor		 0.00 1.20 3.42 2.32 2.82 0.21 1.11 2.28 3.16 1.89 0.72
Debt to Total Capital		 0.00% 0.00% 68.32% 74.34% 71.75% 73.02% 70.81% 68.19% 50.75% 49.93% 50.55%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 2.65% 1.82% 0.89% 0.00% 0.00% 0.00% 5.03%
Long-Term Debt to Total Capital		 0.00% 0.00% 68.32% 74.34% 69.10% 71.20% 69.92% 68.19% 50.75% 49.93% 45.53%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 100.00% 31.69% 25.66% 28.25% 26.98% 29.19% 31.81% 49.25% 50.08% 49.46%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 5.25 6.13 6.13 1.92 1.91 1.97
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 4.75 5.72 5.74 1.31 1.58 1.76
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 5.11 6.06 6.13 1.92 1.91 1.78
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 9.79 8.15 8.52 2.57 2.54 2.84
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 8.85 7.60 7.98 1.75 2.10 2.53
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 9.54 8.04 8.52 2.57 2.54 2.56
Altman Z-Score		 0.00 0.00 0.00 0.59 0.74 1.26 1.38 1.38 2.14 1.74 1.55
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -0.01% -0.01%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 1.46 1.81 1.31 1.16 1.20 1.19 1.22 1.50 1.23 1.07
Quick Ratio		 0.00 0.87 1.20 0.86 0.72 0.74 0.64 0.67 0.96 0.66 0.52
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 -10,884 -10,050 -10,328 1,579 3,360 1,631 3,461 1,136 -1,078
Operating Cash Flow to CapEx		 746.97% 621.59% 433.33% 612.07% 181.72% 172.44% 26.61% 153.64% 78.35% 150.79% -225.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 42.21 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.93 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.26 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.59 0.00 0.00 0.00 0.58 0.57 0.57 0.59 0.58 0.58
Accounts Receivable Turnover		 0.00 6.24 0.00 0.00 0.00 6.49 7.13 6.52 6.71 6.90 7.21
Inventory Turnover		 0.00 4.09 0.00 0.00 0.00 4.02 4.27 4.10 3.86 3.81 3.92
Fixed Asset Turnover		 0.00 5.63 0.00 0.00 0.00 5.36 6.18 5.89 5.73 5.65 6.03
Accounts Payable Turnover		 0.00 7.35 0.00 0.00 0.00 6.69 6.34 6.70 6.28 5.94 5.88
Days Sales Outstanding (DSO)		 0.00 58.47 0.00 0.00 0.00 56.20 51.20 55.96 54.37 52.90 50.61
Days Inventory Outstanding (DIO)		 0.00 89.27 0.00 0.00 0.00 90.83 85.47 89.03 94.68 95.68 93.18
Days Payable Outstanding (DPO)		 0.00 49.69 0.00 0.00 0.00 54.59 57.61 54.44 58.12 61.48 62.10
Cash Conversion Cycle (CCC)		 0.00 98.05 0.00 0.00 0.00 92.45 79.07 90.55 90.92 87.10 81.68
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 11,472 11,158 10,276 10,529 10,207 8,346 8,832 8,481 9,207 9,490
Invested Capital Turnover		 0.00 0.71 0.00 0.00 0.00 0.76 0.85 0.88 0.88 0.86 0.93
Increase / (Decrease) in Invested Capital		 0.00 0.00 11,158 10,276 10,529 -1,265 -2,812 -1,444 -2,048 -1,000 1,144
Enterprise Value (EV)		 0.00 0.00 0.00 16,542 19,378 18,660 20,533 20,444 16,152 17,901 15,848
Market Capitalization		 0.00 0.00 0.00 9,133 12,041 11,412 13,154 13,121 12,657 13,744 11,329
Book Value per Share		 $0.00 $67.55 $22.30 $16.60 $18.48 $17.13 $18.86 $21.07 $28.76 $29.12 $28.65
Tangible Book Value per Share		 $0.00 $12.91 ($31.42) ($36.50) ($35.04) ($34.51) ($23.67) ($22.72) ($14.40) ($18.71) ($18.17)
Total Capital		 0.00 11,666 12,154 11,173 11,301 10,969 11,175 11,460 10,123 10,084 10,049
Total Debt		 0.00 0.00 8,303 8,306 8,109 8,010 7,913 7,815 5,137 5,035 5,080
Total Long-Term Debt		 0.00 0.00 8,303 8,306 7,809 7,810 7,813 7,815 5,137 5,035 4,575
Net Debt		 0.00 -194 7,307 7,409 7,337 7,248 7,379 7,323 3,495 4,157 4,519
Capital Expenditures (CapEx)		 66 88 102 58 93 127 109 110 97 63 84
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 597 509 -105 -22 -16 53 96 -173 -155 181
Debt-free Net Working Capital (DFNWC)		 0.00 791 1,505 792 750 746 587 588 1,469 723 742
Net Working Capital (NWC)		 0.00 791 1,505 792 450 546 487 588 1,469 723 237
Net Nonoperating Expense (NNE)		 3.68 10 37 137 79 283 411 97 147 73 53
Net Nonoperating Obligations (NNO)		 0.00 -194 7,307 7,409 7,337 7,248 5,084 5,187 3,495 4,158 4,521
Total Depreciation and Amortization (D&A)		 144 139 139 133 133 150 129 122 121 117 135
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 7.28% 0.00% 0.00% 0.00% -0.19% 0.64% 1.14% -2.06% -1.86% 2.19%
Debt-free Net Working Capital to Revenue		 0.00% 9.65% 0.00% 0.00% 0.00% 9.04% 7.07% 7.01% 17.48% 8.68% 8.98%
Net Working Capital to Revenue		 0.00% 9.65% 0.00% 0.00% 0.00% 6.62% 5.86% 7.01% 17.48% 8.68% 2.87%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $1.57 $1.37 $0.51 $0.70 $0.19 $0.79 $0.52 $7.26 $0.37 $0.07
Adjusted Weighted Average Basic Shares Outstanding		 0.00 172.70M 172.70M 173.20M 173.40M 173.20M 173.70M 174.10M 174.30M 174.10M 174.20M
Adjusted Diluted Earnings per Share		 $0.00 $1.57 $1.37 $0.51 $0.70 $0.18 $0.78 $0.51 $7.22 $0.37 $0.07
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 172.70M 172.70M 173.50M 173.90M 173.70M 174.80M 175.20M 175.40M 175.30M 175.50M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 172.71M 172.71M 172.75M 172.99M 173.01M 173.39M 173.45M 173.49M 173.17M
Normalized Net Operating Profit after Tax (NOPAT)		 464 282 274 226 201 95 106 187 144 88 66
Normalized NOPAT Margin		 22.36% 13.87% 13.61% 10.87% 9.65% 4.59% 5.14% 8.65% 6.86% 4.38% 3.28%
Pre Tax Income Margin		 24.11% 19.20% 16.32% 4.61% 8.02% 0.63% 1.84% 4.77% 72.23% 2.90% 0.80%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 20.55 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 17.23 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 19.37 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 16.05 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Solventum Corp (NYSE: SOLV) has shown some stability in operating cash flow and a modest uptick in quarterly net income in the latest period, but revenue and gross margin have softened slightly versus the prior-year quarter. Below is a concise, investor-focused read on trends from the last four years, with emphasis on the four most recent quarters provided (Q1–Q4 2025) and nearby prior periods for context.

  • Net income growth in the latest quarter: Net income attributable to common shareholders rose to $63.0 million in Q4 2025 from $30.0 million in Q4 2024 (EPS $0.37 vs $0.19). This suggests improved profitability at the bottom line despite revenue fluctuations.
  • Operating expense discipline: Total operating expenses declined to $902.0 million in Q4 2025 from $983.0 million in Q4 2024, helping support margins even as revenue dipped.
  • Positive operating cash flow across 2025 quarters: Net cash from continuing operating activities remained positive in 2025, with Q4 2025 at $95.0 million, and other 2025 quarters showing meaningful cash generation (e.g., Q2 2025, Q3 2025, and Q1 2025). This points to ongoing cash-generating operations.
  • Improved earnings per share in Q4 2025: Basic and diluted EPS reached $0.37 in Q4 2025, up from $0.19 in Q4 2024, indicating improved profitability on a per-share basis.
  • Liquidity appears solid in recent quarters: Current assets exceed current liabilities, with a rough working-capital cushion and a current ratio near 1.5x in recent periods, implying reasonable near-term liquidity.
  • Revenue level and trajectory: Quarter-to-quarter revenue hovers around $2.0 billion, with a slight year-over-year dip from Q4 2024 to Q4 2025. This is a neutral point for longer-term revenue trend analysis until clearer growth catalysts emerge.
  • Moderate R&D and SG&A trends: R&D declined modestly (e.g., $174 million in Q4 2025 vs $199 million in Q4 2024); SG&A also eased modestly. These shifts are neutral for the overall operating trajectory unless accompanied by strategic R&D investments or sales growth.
  • Shares outstanding relatively stable: Weighted-average basic shares in the 173–174 million range across recent quarters, with similar diluted counts, suggesting limited dilution pressure in the near term.
  • High leverage risk: Long-term debt sits around $8.3 billion, with total liabilities near $11–12 billion and equity in the low-to-mid single billions. The leverage level could pose refinancing and interest-cost challenges if cash flow deteriorates.
  • Material cash outflow from investing activities in parts of 2025: Q3 2025 saw a large negative investing cash flow (Net Cash From Investing Activities around -$3.766 billion), contributing to substantial cash burn in that period and highlighting one-off or ramp-up asset investments that may not recur each quarter.
05/14/26 04:16 AM ETAI Generated. May Contain Errors.

Solventum Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Solventum's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Solventum's net income were at $1.56 billion at the end of 2025, a 224.8% increase from 2024, and a 15.9% increase since 2022. View Solventum's forecast to see where analysts expect Solventum to go next.

Solventum's total operating income in 2025 was $2.18 billion, based on the following breakdown:
  • Total Gross Profit: $4.45 billion
  • Total Operating Expenses: $2.27 billion

Over the last 3 years, Solventum's total revenue changed from $8.13 billion in 2022 to $8.33 billion in 2025, a change of 2.4%.

Solventum's total liabilities were at $9.25 billion at the end of 2025, a 19.6% decrease from 2024, and a 306.0% increase since 2023.

In the past 2 years, Solventum's cash and equivalents has ranged from $194 million in 2023 to $878 million in 2025, and is currently $878 million as of their latest financial filing in 2025.

Over the last 3 years, Solventum's book value per share changed from 0.00 in 2022 to 29.12 in 2025, a change of 2,911.5%.


Related Companies

Financial statements for NYSE:SOLV last updated on 5/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Is this AI lab Elon’s SpaceX lifeline?
Elon Musk went from calling one AI lab 'evil' to striking a deal giving it access to SpaceX's entire Colossus ...
Chaikin Analytics | Sponsoredtc pixel
The one number Musk can't hide in the S-1
When SpaceX files its S-1 in June, one number will stand out - power consumption. Running 1 million GPUs requi...
Behind the Markets | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel
The system holding the dollar together is gone…
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel
SpaceX IPO Warning: Before you buy any SpaceX shares, read this.
The SpaceX IPO is valued at $1.75 trillion - but buying shares directly may not be the strongest play availabl...
Weiss Ratings | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
Millionaire trader: “Buy this before May 15.”
Hedge fund legend Larry Benedict - who beat the S&P 500 by 18 times in 2025 and generated $95 million for clie...
Brownstone Research | Sponsoredtc pixel